| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.06 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.07 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.07 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |